FDA Inspection 544221 — AlloSource

AlloSource — FEI 3005875823

The FDA completed an inspection of AlloSource on October 3, 2008 in Tracy, CA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 6 citations were issued during this inspection. Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
October 3, 2008
Fiscal Year
2009
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Tracy, CA (United States)

Citations

IDCFRDescription
1233621 CFR 1271.180(a)Procedures to meet core CTGP
1233921 CFR 1271.180(c)Availability of procedures
1236521 CFR 1271.195(d)Documentation not maintained
1237021 CFR 1271.200(c)Calibration procedures and schedules (general)
1240221 CFR 1271.230(c)Changes to validated process
1242921 CFR 1271.265(d)Shipping conditions appropriate